TY - JOUR T1 - Impact of Vaccination and Testing in an Urban Campus model for the SARS-CoV-2 Pandemic <sup>*</sup> JF - medRxiv DO - 10.1101/2021.02.02.21251040 SP - 2021.02.02.21251040 AU - Yi Zhang AU - Sanjiv Kapoor Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/05/2021.02.02.21251040.abstract N2 - The crisis induced by the Coronavirus pandemic has severely impacted educational institutes. Even with vaccination efforts underway, it is not clear that sufficient confidence will be achieved for schools to reopen soon.This paper considers the impact of vaccination rates and testing rates to reduce infections and hospitalizations and evaluates strategies that will allow educational institute in urban settings to reopen. These strategies are also applicable to businesses and would help plan reopening in order to help the economy.Our analysis is based on a graph model where nodes represent population groups and edges represent population exchanges due to commuting populations. The commuting population is associated with edges and is associated with one of the end nodes of the edge during part of the time period and with the other node during the remainder of the time period. The progression of the disease at each node is determined via compartment models, that include vaccination rates and testing to place infected people in quarantine along with consideration of asymptomatic and symptomatic populations. Applying this to a university population in Chicago with a substantial commuter population, chosen to be 80% as an illustration, provides an analysis which specifies benefits of testing and vaccination strategies over a time period of 150 days.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunded by NSF grant No. 2028274.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval provided by IRB Illinois Institute of Technology: Exempt Research. Exemption Category: Category 4. Secondary research for which consent is not required. (ii) Information, which may include information about biospecimens, is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained directly or through identifiers linked to the subjects, the investigator does not contact the subjects, and the investigator will not re-identify subjects;All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from public sources was used and referenced. https://github.com/CSSEGISandData/COVID-19. ER -